Published in Cancer Weekly, August 30th, 1999
Corixa Corp., Seattle, Washington, announced that Steven Reed, Ph.D., CSO, presented data on mammaglobin at IBC's conference on immunotherapy for cancer.
Using gene expression analyses, Corixa examined a panel of 25 breast tumors of different stages, along with a variety of normal tissues. Confirmed by quantitative PCR evaluation, mammaglobin expression was observed in the majority of the breast tumors examined, but was absent in non-breast normal tissues. Together, Corixa scientists believe these results...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.